RESEARCH SUMMARY
The Human Retrovirus Section designed, developed and tested vaccines and immunotherapies for AIDS and cancer. We developed and tested new technologies including nucleic acid delivery methods in vivo, prophylactic and therapeutic vaccines and immunotherapies. We studied the role and application of cytokines in vaccines and cancer immunotherapy.

The Human Retrovirus Section focused on the development of innovative vaccines and immunotherapies for AIDS and cancer based on the understanding of basic mechanisms, and by combining our expertise in molecular biology, virology and immunology.